Volume 15, Issue 60 (5-2007)                   J Adv Med Biomed Res 2007, 15(60): 93-98 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moghimi M, Karimi M, Alimoghadam K. Acute Myelogenous Leukemia (AML-M3) in a Patient with Sjögren’s Syndrome. J Adv Med Biomed Res 2007; 15 (60) :93-98
URL: http://journal.zums.ac.ir/article-1-239-en.html
1- Vali-e-Asr Hospital, Zanjan, Iran , mmoghimi2000@yahoo.com
Abstract:   (170316 Views)

Sjögren’s syndrome (SS) is a systemic autoimmune disease that presents with sicca symptoms of the main mucosal surfaces. The spectrum of disease extends from sicca syndrome to systemic involvement and may be complicated by the development of lymphoma. Many types of malignant and pseudo malignant diseases have been reported, but the most important is non Hodgkin lymphoma. We here present a 45 year-old woman with SS that referred with pancytopenia. By molecular and histochemical techniques a diagnosis of acute myeloblastic leukemia of M3 type (AML-M3) was made for this patient.

Full-Text [PDF 140 kb]   (160746 Downloads)    

Received: 2008/06/12 | Accepted: 2014/06/29 | Published: 2014/06/29

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb